Compare Stocks
Compare up to 5 stocks side by side with metrics, growth rates, and performance charts
Select Stocks
CRSP
ERAS
Add up to 3 more stocks
CRSP
CRISPR Therapeutics AG
-5.09%
$54.42-2.92Delayed quote: Oct 6, 2026, 2:35 PM EDT
Market Cap
$5.25B
52W Range
$44.12 - $78.48
ERAS
Erasca, Inc.
-2.40%
$14.37-0.35Delayed quote: Oct 6, 2026, 2:35 PM EDT
Market Cap
$4.99B
52W Range
$1.06 - $24.28
| Metric | ||
|---|---|---|
| ValuationTTM multiples, at last close | ||
| P/E Ratio | N/A | N/A |
| Forward P/E | N/A | N/A |
| PEG Ratio | N/A | N/A |
| P/B Ratio | 3.01 | 13.78 |
| P/S Ratio | 391.93 | N/A |
| P/FCF Ratio | N/A | N/A |
| EV/EBITDA | N/A | N/A |
| Profitabilitytrailing twelve months | ||
| Gross Margin | -6537.0% | 0.0% |
| Operating Margin | -16191.4% | 0.0% |
| Net Margin | -3368.7% | 0.0% |
| ROE | -25.8% | -79.4% |
| ROA | -17.0% | -66.0% |
| ROIC | -21.1% | -38.0% |
| Financial Healthlatest reported quarter | ||
| Current Ratio | 17.85 | 8.29 |
| Quick Ratio | 17.85 | 8.29 |
| Debt/Equity | 0.45 | 0.12 |
| Interest Coverage | N/A | N/A |
| Dividendstrailing dividends vs latest price | ||
| Dividend Yield | N/A | N/A |
| Payout Ratio | N/A | N/A |
| Yrs of Dividend Growth | 0 | 0 |
N/A includes missing data and metrics withheld while their applicability to the company is unverified. Bars show each value's size relative to the row's largest — a factual magnitude cue, not a rating. Tap a metric name for its full history.